| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 12/07/2006 | US20060275362 Rapidly-dissolving pharmaceutical composition for inhibiting ovulation |
| 12/07/2006 | US20060275361 Rapidly dissolving gelatin compositions and products made therefrom |
| 12/07/2006 | US20060275360 Oral dosage forms comprising progesterone and methods of making and using the same |
| 12/07/2006 | US20060275359 Palliative effects of morinda citrifolia oil and juice |
| 12/07/2006 | US20060275358 Self-microemulsifying dosage forms of low solubility active ingredients such as co-enzyme Q10 |
| 12/07/2006 | US20060275357 Organic compounds |
| 12/07/2006 | US20060275356 Pharmaceutical compositions for treating or preventing coronary artery disease |
| 12/07/2006 | US20060275354 Percutaneous absorption-type pharmaceutical preparation |
| 12/07/2006 | US20060275353 Stable topical drug delivery compositions |
| 12/07/2006 | US20060275349 Coated antimicrobial articles |
| 12/07/2006 | US20060275348 Method for preventing or treating thrombosis |
| 12/07/2006 | US20060275347 Fibrous structures comprising a polymer structure |
| 12/07/2006 | US20060275343 The applicator assembly includes a sleeve that encases a swab having a portion that contacts a gelled composition; sleeve is manually severed to expose the applicator and the composition; gelled matrix containing, glycerin, NaCl, hydroxyethyl cellulose, zinc gluconate, benzalkonium chloride, and NaOH |
| 12/07/2006 | US20060275339 Use of antiseptic active principles in pmma bone cements |
| 12/07/2006 | US20060275331 Pharmaceutical composition, method of manufacturing and therapeutic use thereof |
| 12/07/2006 | US20060275305 HERCEPTIN adjuvant therapy |
| 12/07/2006 | US20060275298 Antagonist of Th-1 immuneresponse inducing cytokine for the treatment of autoimmune diseases |
| 12/07/2006 | US20060275270 In vitro mucosal tissue equivalent |
| 12/07/2006 | US20060275251 Polymer complexes of glucuronoglucanes |
| 12/07/2006 | US20060275248 Methods and devices for infant feeding |
| 12/07/2006 | US20060275241 Cosmetic towelette product |
| 12/07/2006 | US20060275222 chewing gums, candies, and an edible films; with peppermint oil |
| 12/07/2006 | US20060275221 containing a saccharide for use in the treatment of dermal disorders including H2O; a saccharide; a nonionic surfactant such as polyoxyethylene glycol sorbitan monostearate, a polymeric agent selected from a bio-adhesive agent, gelling agent; film forming agent; phase change agent; adjuvant; propellant |
| 12/07/2006 | US20060275219 Radial spherical crystallization product, process for producing the same, and dry powder preparation containing the crystallization product |
| 12/07/2006 | DE60118395T2 Pharmazeutische zusammensetzungen mit verzögerter freisetzung für die parenterale applikation von hydrophilen wirkstoffen Pharmaceutical compositions of active ingredients with controlled release for the parenteral administration of hydrophilic |
| 12/07/2006 | DE202005020881U1 Psychostimulans enthaltende pharmazeutische Zusammensetzung Psychostimulant containing pharmaceutical composition |
| 12/07/2006 | DE102005025283A1 Stabiler Wirkstoffkomplex von Salzen der o-Acetylsalicylsäure mit basischen Aminosäuren und Glycin Stable ingredient complex salts of O-acetylsalicylic acid with basic amino acids and glycine |
| 12/07/2006 | DE102005025057A1 Verfahren zum Herstellen von Nanopartikeln unter Verwendung poröser Membranen A method of producing nanoparticles using porous membranes |
| 12/07/2006 | CA2611147A1 Topical emulsion formulation |
| 12/07/2006 | CA2611144A1 Compositions comprising a lipid and copolymer of styrene and maleic acid |
| 12/07/2006 | CA2611133A1 Rapidly-dissolving pharmaceutical composition for inhibiting ovulation |
| 12/07/2006 | CA2610708A1 Method and composition for transdermal drug delivery |
| 12/07/2006 | CA2610626A1 Method for terminal sterilization of transdermal delivery devices |
| 12/07/2006 | CA2610414A1 Skin patch |
| 12/07/2006 | CA2610403A1 Nanoparticles comprising chitosan and cyclodextrin |
| 12/07/2006 | CA2610245A1 Method for terminal sterilization of transdermal delivery devices |
| 12/07/2006 | CA2609926A1 Electrostatic patch for allergen screening and applicator for same |
| 12/07/2006 | CA2609579A1 Stable liquid desoximetasone compositions with reduced oxidized impurity |
| 12/07/2006 | CA2609352A1 Delivery systems |
| 12/07/2006 | CA2608432A1 Bioresorbable polymer matrices and methods of making and using the same |
| 12/06/2006 | EP1728791A1 Composition for solid pharmaceutical preparation of solifenacin or salt thereof |
| 12/06/2006 | EP1728550A1 Method for producing coated fine particles |
| 12/06/2006 | EP1728532A1 Method and system for myocardial infarction repair |
| 12/06/2006 | EP1728512A1 Controlled-leaching preparation and process for producing the same |
| 12/06/2006 | EP1728506A1 Coenzyme q composition with long-term persistence in blood |
| 12/06/2006 | EP1728505A1 Preparation with elevated content |
| 12/06/2006 | EP1728504A1 Emulsion stabilizer |
| 12/06/2006 | EP1727865A1 Particle-stabilised emulsions |
| 12/06/2006 | EP1727593A1 Dermal patch for iontophoresis |
| 12/06/2006 | EP1727561A1 Lactalbumin for inhibiting angiogenesis |
| 12/06/2006 | EP1727553A2 Agent for substitution of blood plasma and a method of its production |
| 12/06/2006 | EP1727549A1 Intranasal benzodiazepine compositions |
| 12/06/2006 | EP1727543A1 Use of 14,15-dihydro-20,21-dinoreburnamenin-14-ol for the treatment and/or prevention of serious depression and sleep/waking cycle disorders |
| 12/06/2006 | EP1727532A2 Chemically stable compositions of 4-hydroxy tamoxifen |
| 12/06/2006 | EP1727530A2 Topical formulations for the treatment of skin conditions |
| 12/06/2006 | EP1727525A1 Chitosan embedded or encapsulated capsule |
| 12/06/2006 | EP1727524A1 Preparation of lipid coated cefuroxime axetil |
| 12/06/2006 | EP1727523A2 Pharmaceutical formulation containing unmilled flutamide |
| 12/06/2006 | EP1727522A2 Cosmetic and pharmaceutical foam with solid matter |
| 12/06/2006 | EP1727521A1 Bioavailable nutritional supplement and method of treatment of malabsorption |
| 12/06/2006 | EP1727520A2 Method of preparation of mixed phase co-crystals with active agents |
| 12/06/2006 | EP1727437A1 Stable coating agent comprising sterol |
| 12/06/2006 | EP1727436A1 Method of preparing a protein aggregate and a pharmaceutical composition |
| 12/06/2006 | EP1684739A4 Treatment and prevention of liver disease associated with parenteral nutrition (pn) |
| 12/06/2006 | EP1631146A4 Treatment of cancer with active vitamin d compounds in combination with radiotherapeutic agents and treatments |
| 12/06/2006 | EP1615632B1 Floating oral formulations for controlled release of betaine |
| 12/06/2006 | EP1601339A4 Skin peeling composition and method |
| 12/06/2006 | EP1490096B1 Use of hydrogen peroxide producing enzyme for treatment of otitis media |
| 12/06/2006 | EP1487462A4 Preparations for topical skin use and treatment |
| 12/06/2006 | EP1458369B1 Gel comprising at least a retinoid and benzoyl peroxide |
| 12/06/2006 | EP1408897A4 Gum resin as a carrier for topical application of pharmacologically active agents |
| 12/06/2006 | EP1397135B1 Combination of a pde4 inhibitor and tiotropium or derivative thereof for treating obstructive airways |
| 12/06/2006 | EP1345610B1 Quetiapine for treating of dyskinesia in non-psychotic patients |
| 12/06/2006 | EP1339282A4 Hydrophilic polymer blends used for dry cow therapy |
| 12/06/2006 | EP1315481B1 Medicament for treating intestinal diseases |
| 12/06/2006 | EP1212050B1 Formulations containing tetracyclines for treating or preventing mucositis |
| 12/06/2006 | EP1137411B1 Palladium-substituted bacteriochlorophyll derivatives and use thereof |
| 12/06/2006 | EP0996425B1 A delivery system for an oral care substance using a strip of material having low flexural stiffness |
| 12/06/2006 | EP0644771B2 Erythropoietin drug delivery system |
| 12/06/2006 | CN2843452Y Huoluo medicinal paste |
| 12/06/2006 | CN2843451Y Externally-applied medicinal paste for treating asthma |
| 12/06/2006 | CN2843450Y Pasting membrane |
| 12/06/2006 | CN2843449Y Externally-applied plaster for treating acute sprain and contuse |
| 12/06/2006 | CN1875022A Tocopherol-modified therapeutic drug compounds |
| 12/06/2006 | CN1874977A Process for the preparation of 1-octene |
| 12/06/2006 | CN1874976A Process for producing 1-octene from butadiene in the presence of titanium catalysts |
| 12/06/2006 | CN1874817A Powder inhaler |
| 12/06/2006 | CN1874786A Botulinum toxin treatments of neurological and neuropsychiatric disorders |
| 12/06/2006 | CN1874778A Pharmaceutical formulation comprising a pyrimidine-A-one derivative coated with an enteric polymer |
| 12/06/2006 | CN1874774A Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester |
| 12/06/2006 | CN1874770A Therapeutic agent for keratoconjunctiva disorder |
| 12/06/2006 | CN1874767A Sustained release pharmaceutical compositions comprising APLINDORE and derivatives thereof |
| 12/06/2006 | CN1874764A Sustained-release microgranules containing ginkgo biloba extract and the process for manufacturing these |
| 12/06/2006 | CN1874763A Modular imbibition rate reducer for use with implantable osmotic pump |
| 12/06/2006 | CN1874762A New formulation for retinoid-containing soft gelatin capsules |
| 12/06/2006 | CN1874761A Sustained release dosage forms of ziprasidone |
| 12/06/2006 | CN1874760A Melt-formulated, multi-particulate oral dosage form |
| 12/06/2006 | CN1874759A Process for producing coated preparation having relieved unpleasantness |
| 12/06/2006 | CN1874758A Compositions comprising fenofibrate and pravastatin |
| 12/06/2006 | CN1874757A Mucoactive agents for treating a pulmonary disease |